According to the Zhitong Finance App, Hengrui Pharmaceutical (01276) announced that on October 22, 2026, it spent about 6.9152 million yuan to buy back 150,000 A-shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.